NanoGroup S.A. (WSE: NNG)
Poland
· Delayed Price · Currency is PLN 3.160
+0.050 (1.61%)
Jan 21, 2025, 9:47 AM CET
NanoGroup Revenue
NanoGroup had revenue of 7.00K PLN in the quarter ending September 30, 2024, with 16.67% growth. This brings the company's revenue in the last twelve months to 2.02K, down -108.61% year-over-year. In the year 2023, NanoGroup had annual revenue of 2.02K, down -98.55%.
Revenue
2.02K
Revenue Growth
-108.61%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
88.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | 687.51K | 169.78K | 32.79% |
| Dec 31, 2019 | 517.73K | 206.93K | 66.58% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Oct 29, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.34B |
| Synektik Spólka Akcyjna | 624.80M |
| Voxel | 492.41M |
| Celon Pharma | 209.54M |
| Selvita | 334.42M |
| Ryvu Therapeutics | 91.18M |
| Centrum Medyczne ENEL-MED | 680.32M |
| Mercator Medical | 488.78M |